Skip to main content
. 2013 Nov;15(11):1241–1250. doi: 10.1593/neo.131468

Figure 5.

Figure 5

At 24 hours posttreatment, B20.4.1.1 exhibited a significant decrease in viable tumor pO2. (A) The B20.4.1.1-treated group showed no significant change in viable tumor volume (NS, P > .05). (B) The viable tumor pO2 was significantly reduced in the B20.4.1.1 group relative to the pretreatment level (###P < .001) as well as in comparison with the control group (*P < .05). (C) Images showing pO2 change after 24 hours.